BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2004
View Archived Issues
A preclinical trial suggests that histamine protects the liver against LPS-induced damage
Read More
Therapeutic benefits of Pegasys plus ribavirin in HCV-infected patients
Read More
Synthetic truncated PSP94 for metastatic hormone-resistant prostate cancer patients
Read More
VaxGen anthrax vaccine candidate prepares to enter phase II trial
Read More
Preclinical, preliminary clinical data on GW-280430A, a nondepolarizing neuromuscular blocking agent
Read More
Benefits of statins and ACE inhibitors in coronary heart disease
Read More
Sinapultide equivalent to poractant alfa in the prevention of RDS
Read More
ABI-793 shows promise, complications in renal transplant model
Read More
TAK-559, a PPARalpha/gamma coagonist for the treatment of dyslipidemia
Read More
Atherosclerosis in LDLR mice inhibited by PPARdelta ligand GW-0742
Read More
Novel cytotoxic agent effective against chemotherapy-resistant ovarian carcinoma
Read More
Selective acetylcholinesterase inhibitor effective against bladder voiding dysfunction
Read More
New data on Fujisawa's histone deacetylase inhibitor FR-901228
Read More
R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: MacroChem
Read More
R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Newron
Read More
R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Munich Biotech
Read More
Novel BH3-derived proapoptotic peptides developed by Dana Farber researchers
Read More
New IKK inhibitors and their use reported by Aventis Pharma
Read More
Novo Nordisk claims the preparation and use of novel PPARdelta agonists
Read More
New ORL1 receptor modulators with potential in anxiety and other disorders
Read More
CV Therapeutics describes adenosine A3 agonists for cancer and neutropenia therapy
Read More
Two series of histamine H4 antagonists prepared and tested at Janssen
Read More
Phase III results of R-1549 in ovarian cancer disappoint
Read More
European CPMP recommends broader indication for Remicade in early RA
Read More
Phase III trial of Tarceva in NSCLC meets endpoints
Read More
Genmab licenses GT43 cancer target from Ganymed
Read More
CRX-675 enters phase I trial for seasonal allergic rhinitis
Read More
ViRexx Medical receives grant to fund phase I trial of Occlusin
Read More
Levitra receives Japanese approval
Read More
Phase II/III trial of Fibrillex cleared to continue
Read More